What Is Your Parkinson’s Clinical Research IQ?
How much do you know about clinical research? Find out with this five-question quiz.
Then use the Parkinson's Disease Foundation (PDF) resources to improve your knowledge and become an advocate for Parkinson's therapies development.
Please begin by a username below ("anonymous" will be accepted) and then proceed to question #1. Please note PDF will not save, use or distribute these names.
- 1.
The average time it takes for a drug to be developed and approved is:
- A.
Six months to one year
- B.
One to two years
- C.
Three to five years
- D.
10 to 15 years
Correct Answer
D. 10 to 15 yearsExplanation
The average time it takes for a drug to be developed and approved is 10 to 15 years. This is because the process of drug development involves several stages, including preclinical testing, clinical trials, regulatory review, and post-marketing surveillance. Each of these stages requires time for research, testing, analysis, and approval. Additionally, the drug development process also involves ensuring the safety and efficacy of the drug, which further contributes to the lengthy timeline.Rate this question:
-
- 2.
The percentage of clinical trials that are delayed at least one month because of the lack of clinical research participation is:
- A.
10 percent
- B.
40 percent
- C.
25 percent
- D.
80 percent
Correct Answer
D. 80 percentExplanation
Something else to think about… The spending on participant recruitment in the U.S. increased from $275 million in 1998 to $500 million in 2002.Rate this question:
-
- 3.
The percentage of people with Parkinson’s who participate in clinical studies is estimated to be:
- A.
20 percent
- B.
10 percent
- C.
Five percent
- D.
One percent
Correct Answer
D. One percentExplanation
Something else to think about… less than five percent of cancer patients participate in clinical trials. If 10 percent participated, studies could be completed in one year, instead of three to five years. (National Cancer Institute)Rate this question:
-
- 4.
Most people with Parkinson’s learn about clinical studies through:
- A.
Their doctor
- B.
Support groups
- C.
The Internet
- D.
Other people with PD
Correct Answer
B. Support groupsExplanation
Support groups are a common source of information for people with Parkinson's disease to learn about clinical studies. These groups provide a platform for individuals to share their experiences, knowledge, and resources related to Parkinson's disease. Support group members often discuss ongoing clinical trials, research studies, and new treatment options, which can help individuals stay informed about the latest advancements in Parkinson's research. Additionally, support groups offer emotional support, camaraderie, and a sense of community, making them an ideal setting for individuals to learn about and engage in clinical studies.Rate this question:
-
- 5.
A clinical research participant may discontinue participation in a study:
- A.
Whenever the individual wishes
- B.
Only if there are medical concerns
- C.
Only if the study is halted by the sponsor
- D.
Only with authorization from the individual’s physician
Correct Answer
A. Whenever the individual wishesExplanation
Something else to think about… when withdrawing from the trial, the participant should inform the research team and communicate the reasons for leaving the study.Rate this question:
-
Quiz Review Timeline +
Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.
-
Current Version
-
Mar 17, 2023Quiz Edited by
ProProfs Editorial Team -
Oct 25, 2010Quiz Created by
Mbarrypdf
Back to top